Gujarat Inject (Kerala) MD, chairman, board of directors and AGM
BSE: 524238Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹9.79.
- The board meets on 26 Oct 2026 to consider: issue of warrants and preferential issue of shares.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- Differs from the exchange's2,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Differs from the exchange's
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Differs from the exchange's
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- –
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 32.9%
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,31,147
Gujarat Inject (Kerala) board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.
- Company Secretary and Compliance OfficerMANMEETKAUR HARSHDEEPSINGH BHATIA
3 directors3 independent
- RUSHIRAJ ZAVERBHAI PATELIndependent · joined Jul 2025 · reappointed Jul 2025 · 11 months as independent · 3 listed boards · 3 as independent · 5 committee seats, 4 as chair
- NILESHBHAI VINUBHAI RANGHOLIYAIndependent · joined Jul 2025 · reappointed Jul 2025 · 11 months as independent · 1 listed board · 1 as independent · 1 committee seat
- ILA TRIVEDIIndependent · joined Feb 2026 · reappointed Feb 2026 · 4 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 2 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
5 directors who left
- DEEPAK DIWAN BACHWANI, left 23 Jun 2026: Others
- MURLI SHIVSHANKARAN NAIR, left 16 May 2026: Others
- REENA MAHATMA, left 9 Dec 2025: Others
- NARAYANSINH CHAUHAN, left 15 Jul 2025: Others
- GAUTAM KESHAVLAL CHAUHAN, left 15 Jul 2025: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 29 Jun 20263 of 3 present3 independent · 1 day in between
- 27 Jun 20263 of 3 present3 independent · 37 days in between
- 20 May 20264 of 4 present3 independent · 3 days in between
- 16 May 20264 of 4 present3 independent
Audit Committee
Chair RUSHIRAJ ZAVERBHAI PATEL
NILESHBHAI VINUBHAI RANGHOLIYA, ILA TRIVEDI
- 20 May 20263 of 3 present3 independent
Nomination and remuneration committee
Chair RUSHIRAJ ZAVERBHAI PATEL
NILESHBHAI VINUBHAI RANGHOLIYA, ILA TRIVEDI
- 16 May 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair RUSHIRAJ ZAVERBHAI PATEL
NILESHBHAI VINUBHAI RANGHOLIYA, ILA TRIVEDI
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- S Mandawat & Co. Charted AccountantNo peer-review certificate stated
1 earlier auditor
- M/s. S. Mandawat & Co.Named in filings from Mar 2025 to Mar 2026
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Gujarat Inject (Kerala) AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Gujarat Inject (Kerala) share news and announcements
Annual general meeting, 29 Sep 2026
18,149 shareholders on the register on 22 Sep 2026; present: 0 promoters and 35 others; votes counted by Mr. Utkarsh Shah / M/s. Utkarsh Shah & Co..The company's voting result (opens in a new tab)
To receive, consider, approve and adopt the Annual Audited Standalone Financial Statements of the Company for the Financial Year ended on March 31, 2026 together with the Reports of the Board of Directors and the Auditors thereon.MoreLess
Ordinary99.42% for0.58% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.58%
Turnout: all 25.98% · promoters 0.00% · institutions 0.00% · other public 25.98%
- To appoint a director in place of Mr. Murli Shivshankaran Nair (DIN -02243039) who retires by rotation and being eligible, seeks re-appointment.Ordinary99.42% for0.58% against
Against: promoters 0.00% · institutions 0.00% · other public 0.58%
Turnout: all 25.98% · promoters 0.00% · institutions 0.00% · other public 25.98%
- APPOINTMENT OF STATUTORY AUDITORSOrdinary99.42% for0.58% against
Against: promoters 0.00% · institutions 0.00% · other public 0.58%
Turnout: all 25.98% · promoters 0.00% · institutions 0.00% · other public 25.98%
- REGULARISATION OF INDEPENDENT DIRECTORSpecial99.42% for0.58% against
Against: promoters 0.00% · institutions 0.00% · other public 0.58%
Turnout: all 25.98% · promoters 0.00% · institutions 0.00% · other public 25.98%
- REGULARISATION OF EXECUTIVE MANAGING DIRECTORSpecialPromoters have an interest in it99.42% for0.58% against
Against: promoters 0.00% · institutions 0.00% · other public 0.58%
Turnout: all 25.98% · promoters 0.00% · institutions 0.00% · other public 25.98%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 19 Aug 2026, 2 resolutions
7,050 shareholders on the register on 5 Aug 2026; present: 0 promoters and 39 others; votes counted by UTKARSH SHAH / UTKARSH SHAH & CO..The company's voting result (opens in a new tab)
- To rescind the special resolution passed by the members of the company at the extraordinary general meeting held on Thursday 3rd April 2025.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 21.34% · promoters 0.00% · institutions 0.00% · other public 21.34%
- Change of name of the company from Gujarat Inject Kerala Limited to Regenova Renewtech Limited.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 21.34% · promoters 0.00% · institutions 0.00% · other public 21.34%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.